Cardiovascular

Home

About

Cardiovascular Program

Cardiovascular_program

Funding

  • NHLBI
  • NIAID

The Cardiovascular and Metabolic Program aims at advancing the knowledge of prevalent cardiovascular and metabolic diseases and accelerating the development of new therapeutic and diagnostic strategies. The program brings together scientists from multiple communities within MGH and Harvard. Collectively, the projects described below undertake a variety of systems-level analyses, including systematic mapping of genetic/functional interactions, functional genomics, and in vivo molecular imaging.

Atherosclerosis/Myocardial infarction

  • Exploring the role of inflammatory networks in ischemic heart disease and stroke
  • Major focus on monocyte/macrophage subsets, their function and ontogeny
  • Chemical biology and genomic studies to assign function to susceptibility alleles for atherosclerosis or myocardial infarction
  • Nanomaterial-based molecular imaging probes to define cellular and enzymatic components of plaque, and monitor disease progression and therapeutic response in pre-clinical studies and clinical trials

Metabolism and energetics

  • Systematic mapping of metabolic pathways in health and disease using mass spectrometry-based metabolomics and proteomics
  • Translational research in metabolic syndrome
  • Functional genomics of mitochondrial function in diabetes and other human diseases

Stem cells and regeneration

  • Role of hematopoietic stem cells in ischemic heart disease and stroke
  • Small molecule approaches to direct differentiation of stem cells into the cardiac lineage
  • Chemical screens in stem cells or model organisms to dissect developmental pathways and manipulate them for therapeutic benefit
  • Nanoparticle-based imaging of transplanted stem cells in vivo

Novel biomarkers for diagnosis, clinical phenotyping and disease status

  • Metabolites
  • Cell-based phenotypes
  • Nanoparticle-based molecular imaging
  • Benchtop parallel measurement of multiplexed analytes

Recent Publications (more...)

Tawakol A, Osborne MT, Wang Y, Hammed B, Tung B, Patrich T, Oberfeld B, Ishai A, Shin LM, Nahrendorf M, Warner ET, Wasfy J, Fayad ZA, Koenen K, Ridker PM, Pitman RK, Armstrong KA
Stress-Associated Neurobiological Pathway Linking Socioeconomic Disparities to Cardiovascular Disease.
J Am Coll Cardiol. 2019;73(25):3243-3255 - PMID: 31248544 - DOI: 10.1016/j.jacc.2019.04.042
Hulsmans M, Nahrendorf M
Smad3 Cranks Up the Appetite of Infarct Macrophages.
Circ Res. 2019;125(1):71-73 - PMID: 31219739 - PMCID: PMC6588180 - DOI: 10.1161/CIRCRESAHA.119.315306
Wang Y, Sano S, Oshima K, Sano M, Watanabe Y, Katanasaka Y, Yura Y, Jung C, Anzai A, Swirski FK, Gokce N, Walsh K
Wnt5a-Mediated Neutrophil Recruitment Has an Obligatory Role in Pressure Overload-Induced Cardiac Dysfunction.
Circulation. 2019;:ePub - PMID: 31170826 - DOI: 10.1161/CIRCULATIONAHA.118.038820
Hoyer FF, Nahrendorf M
Interferon-ɣ regulates cardiac myeloid cells in myocardial infarction.
Cardiovasc Res. 2019;:ePub - PMID: 31161218 - DOI: 10.1093/cvr/cvz143

Recent News (more...)

2018-05-10: "Leaders In Cardiovascular Science" - Circulation Research profiles Fil Swirski. (pdf)
2017-10-04: Aaron Aguirre, MD, PhD has received a 2017 Physician/Scientist Development Award for “Morphology and Dynamic Functions of Pericytes in the Heart.” The project will use state-of-the-art microscopy techniques to better understand the role of pericytes—unique cells that line the outer walls of the smallest blood vessels in the heart.
2017-07-21: "..changing from racing a Ferrari to riding a bicycle (with a flat tire)" - former CBS fellow Florian Leuschner is documenting his transition from a postdoctoral fellowship in the United States to junior faculty in Europe in this Circulation Research paper. (pdf)
2017-07-10: Recent CSB work featured in the NEJM. (pdf)